A Study of Tarlatamab for People With Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The researchers are doing this study to find out whether tarlatamab is an effective treatment for Delta-like Protein 3 (DLL3)-positive prostate cancer that has spread to other parts of your body (metastasized) and has either come back after treatment (relapsed) or not responded to treatment (refractory).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony rozpoznaniem raka prostaty
- •Rak rozprzestrzenił się na inne części ciała (widoczny w badaniach CT, MRI lub scyntygrafii kości)
- •Poziom testosteronu poniżej 50 ng/dL lub podjęcie odpowiedniego leczenia hormonalnego
- •Pogorszenie stanu pomimo wcześniejszego leczenia (widoczne w podwyższonym PSA, wzroście guzów lub nowych zmianach w kościach)
- •Zdolność do wyrażenia świadomej zgody na uczestnictwo w badaniu
- •Saturacja tlenu w spoczynku co najmniej 90% na powietrzu pokojowym
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 31, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (10)
UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)
San Diego, United States
University of California San Francisco
San Francisco, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
Commack, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, United States
Thomas Jefferson University Hospital
Philadelphia, United States
Trial contact
Karen Autio, MD
Michael Morris, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.